Invitrogen™ CTS™ CytoTune™-iPS 2.1 Sendai Reprogramming Kit 

Description

The CTS CytoTune-iPS 2.1 Sendai Reprogramming Kit is the first off-the-shelf reprogramming system designed for clinical and translational research. It delivers efficient, integration-free reprogramming of somatic cells into induced pluripotent stem cells. Like the CytoTune-iPS 2.0 Sendai kit, the CTS CytoTune-iPS 2.1 Sendai kit uses Sendai particles to deliver Yamanaka factors that are critical for efficient generation of induced pluripotent stem cells (iPSCs). This kit includes three vector preparations: polycistronic Klf4–Oct3/4–Sox2 (KOS), L-Myc, and Klf4 and is sufficient to reprogram a minimum of six wells of a six-well plate.

Supports a xeno-free workflow for the generation of iPSC lines

The bovine serum albumin carrier protein was removed from the CTS CytoTune-iPS 2.1 Sendai vector formulation. The preparation contains no animal-derived components at the primary component level, enabling the xeno-free generation of iPSCs from both fibroblasts and blood.

Facilitates customer regulatory filings with extensive testing and traceability documentation

The CTS CytoTune-iPS 2.1 Sendai kit is manufactured at a site with a process that was audited for conformity with current Good Manufacturing Practices for medical devices, 21 CFR Part 820 of the regulation. Full traceability documentation such as Certificate of Origin and Certificate of Analysis are available.